Main Line biotech firm advancing technology to help diagnose, treat prostate …

This entry was posted by ctbenefits on May 4, 2016 at 2:46 AM

ProstaGene is developing gene-based technology to diagnose and treat prostate cancer. iStockphoto. ProstaGene has raised $400,000 from private investors to support commercialization of a gene-based test to help guide prostate cancer treatment.